title: Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators.
abstract: We sought to assess the impact of coronary angiography results on use of lipid-lowering agents among women enrolled in the Women's Ischemia Syndrome Evaluation [WISE] study. WISE is a multicenter study designed to evaluate new diagnostic modalities among women undergoing angiography for suspected coronary artery disease (CAD). History of atherosclerosis, risk factors for CAD, and low-density lipoprotein (LDL) cholesterol are determined at baseline. The percentage of women at LDL cholesterol goal, use of lipid-lowering agents, and eligibility for lipid-lowering therapy were determined based on National Cholesterol Education Program II guidelines at baseline and 6-week follow-up. Among the 212 women for whom angiographic data were available, 84 had known atherosclerosis, 80 had no history of atherosclerosis but > or =2 risk factors (high risk), and 48 had no history of atherosclerosis and <2 risk factors (low risk). At baseline, LDL cholesterol goals were met in 24% women with atherosclerosis, in 56% high-risk women, and in 88% low-risk women. Angiography revealed previously undiagnosed CAD in 70% of the high-risk and in 42% of the low-risk women. After angiography results were available, 6 women started lipid-lowering therapy and 2 stopped. Based on National Cholesterol Education Program II guidelines, 63 additional women would have been eligible for pharmacologic lipid-lowering therapy. Intensification of lipid-lowering therapy was not apparent 6 weeks after coronary angiography in women with newly diagnosed CAD or among women whose diagnosis was confirmed.
authors.affiliation: Division of Cardiovascular Disease, University of Alabama at Birmingham, 35294, USA. vbittner@uab.edu
authors.forename: V
authors.initials: V
authors.lastname: Bittner
authors.forename: M
authors.initials: M
authors.lastname: Olson
authors.forename: S F
authors.initials: SF
authors.lastname: Kelsey
authors.forename: W J
authors.initials: WJ
authors.lastname: Rogers
authors.forename: C N
authors.initials: CN
authors.lastname: Bairey Merz
authors.forename: K
authors.initials: K
authors.lastname: Armstrong
authors.forename: S E
authors.initials: SE
authors.lastname: Reis
authors.forename: A
authors.initials: A
authors.lastname: Boyette
authors.forename: G
authors.initials: G
authors.lastname: Sopko
mesh_terms: D000368:Aged; D008078:Cholesterol, LDL / Q000097:blood; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010818:Practice Patterns, Physicians'; D018570:Risk Assessment
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents